ArticleExploration (Beijing, China)2025
Switching Cathodic/Anodic Electrochemiluminescence of Ru(bpy)
Article in Exploration (Beijing, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and clinical validation of a nursing risk prediction model for chemotherapy-induced febrile neutropenia in patients with cancer.Frontiers in cell and developmental biology · 2026Article
- Switching Cathodic/Anodic Electrochemiluminescence of Ru(bpy)Exploration (Beijing, China) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive oxygen species (ROS) have gained increasing attention in electrochemiluminescence (ECL) as endogenous co-reactants, yet their application in the most widely used tris(bipyridine)-ruthenium(II) system remains limited due to the scarcity of suitable co-reactant accelerators (CRAs) with selective oxygen reduction reaction (ORR) and oxygen evolution reaction (OER) catalytic activity. Here, this work reports a series of facet-tunable homogeneous NiNPs catalysts, which can stimulate ECL at distinguishable cathodic/anodic potentials in tris(bipyridine)-ruthenium(II) system. Experimental studies and theoretical calculation results reveal that the Ni(1 1 0) surface, with its lower charge density, impedes the fourth step of 4e
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.